4.7 Article

Disulfiram/Copper Suppresses Cancer Stem Cell Activity in Differentiated Thyroid Cancer Cells by Inhibiting BMI1 Expression

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biology

Comparative evaluation of BMI-1 proto-oncogene expression in normal tissue, adenoma and papillary carcinoma of human thyroid in pathology samples

Mohadeseh Hajian et al.

Summary: The study evaluated the expression of the BMI-1 gene in thyroid carcinoma, adenoma, and healthy tissues, showing overexpression in papillary carcinoma and adenoma tissues compared to healthy tissues. This suggests BMI-1 as a potential biomarker for thyroid malignancies, warranting further research on its expression in other thyroid cancers.

BMC RESEARCH NOTES (2021)

Article Oncology

Targeting cancer stem cells by disulfiram and copper sensitizes radioresistant chondrosarcoma to radiation

Kun Wang et al.

Summary: This study demonstrates that DSF/Cu can increase the radiosensitivity of chondrosarcoma stem cells, potentially providing better treatment outcomes for chondrosarcoma patients requiring radiotherapy.

CANCER LETTERS (2021)

Article Oncology

E2F1 Maintains Gastric Cancer Stemness Properties by Regulating Stemness-Associated Genes

Yan Fu et al.

Summary: E2F1 plays a significant role in maintaining gastric cancer stemness properties and is closely associated with clinical characteristics and prognosis in gastric cancer patients. High expression of E2F1 is correlated with worse overall survival, suggesting its potential as a prognostic biomarker and therapeutic target in gastric cancer.

JOURNAL OF ONCOLOGY (2021)

Article Multidisciplinary Sciences

EGFR activation limits the response of liver cancer to lenvatinib

Haojie Jin et al.

Summary: Inhibition of EGFR is synthetically lethal with lenvatinib in liver cancer, and the combination of lenvatinib with the EGFR inhibitor gefitinib shows potent anti-proliferative effects both in vitro and in vivo. This combination therapy could be a promising strategy for HCC patients with high levels of EGFR, providing meaningful clinical responses.

NATURE (2021)

Article Oncology

A Yes-Associated Protein (YAP) and Insulin-Like Growth Factor 1 Receptor (IGF-1R) Signaling Loop Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma

Mai-Huong T. Ngo et al.

Summary: The study reveals the involvement of the YAP-IGF-1R signaling loop in HCC sorafenib resistance, with specific inhibitor verteporfin significantly enhancing HCC cell sensitivity to sorafenib in a synergistic manner.

CANCERS (2021)

Review Biochemistry & Molecular Biology

Recent Advances in Repurposing Disulfiram and Disulfiram Derivatives as Copper-Dependent Anticancer Agents

Vinodh Kannappan et al.

Summary: Copper plays a key role in cancer progression and copper-based complexes are being investigated as novel anticancer drugs. The combination of DSF with copper has shown great anticancer potential, but DSF has proven unsuccessful in clinical trials, likely due to poor stability of the currently used oral version of DSF.

FRONTIERS IN MOLECULAR BIOSCIENCES (2021)

Review Biochemistry & Molecular Biology

Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents

He-Ming Zhou et al.

Summary: Understanding the key characteristics and resistance mechanisms of CSCs may improve patient outcomes and reduce relapse. Targeting the mechanisms and pathways of CSCs described in this review could lead to further drug discovery and therapy development.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Review Endocrinology & Metabolism

Updates on the Management of Thyroid Cancer

Katherine A. Araque et al.

HORMONE AND METABOLIC RESEARCH (2020)

Article Medicine, Research & Experimental

Novel Potential Therapeutic Target for E2F1 and Prognostic Factors of E2F1/2/3/5/7/8 in Human Gastric Cancer

Xuhong Liu et al.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)

Article Multidisciplinary Sciences

The pseudogene problem and RT-qPCR data normalization; SYMPK: a suitable reference gene for papillary thyroid carcinoma

Seyed-Morteza Javadirad et al.

SCIENTIFIC REPORTS (2020)

Review Biochemistry & Molecular Biology

Targeting cancer stem cell pathways for cancer therapy

Liqun Yang et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Article Biochemistry & Molecular Biology

Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas

Franz X. Schaub et al.

CELL SYSTEMS (2018)

Review Biochemistry & Molecular Biology

Targeting oncogenic Myc as a strategy for cancer treatment

Hui Chen et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2018)

Article Biochemistry & Molecular Biology

Hsp90α Mediates BMI1 Expression in Breast Cancer Stem/Progenitor Cells through Facilitating Nuclear Translocation of c-Myc and EZH2

Yueh-Chun Lee et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Article Medicine, General & Internal

Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013

Hyeyeun Lim et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)

Article Medicine, Research & Experimental

The evolving concept of cancer stem-like cells in thyroid cancer and other solid tumors

Heather Hardin et al.

LABORATORY INVESTIGATION (2017)

Article Multidisciplinary Sciences

Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4

Zdenek Skrott et al.

NATURE (2017)

Article Biochemistry & Molecular Biology

KLF4 is regulated by RAS/RAF/MEK/ERK signaling through E2F1 and promotes melanoma cell growth

M. Riverso et al.

ONCOGENE (2017)

Review Medicine, General & Internal

Thyroid cancer

Maria E. Cabanillas et al.

LANCET (2016)

Review Oncology

Aldehyde dehydrogenases and cancer stem cells

Xia Xu et al.

CANCER LETTERS (2015)

Article Medicine, General & Internal

Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer

Martin Schlumberger et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Review Medicine, Research & Experimental

Thyroid Cancer

Tobias Carling et al.

ANNUAL REVIEW OF MEDICINE, VOL 65 (2014)

Article Endocrinology & Metabolism

Analysis of multiple markers for cancer stem-like cells in human thyroid carcinoma cell lines

Mika Shimamura et al.

ENDOCRINE JOURNAL (2014)

Article Endocrinology & Metabolism

Detection of Thyroid Cancer Stem Cells in Papillary Thyroid Carcinoma

Soon-Hyun Ahn et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)

Article Biochemistry & Molecular Biology

Sp1 and c-Myc regulate transcription of BMI1 in nasopharyngeal carcinoma

Hong-Bo Wang et al.

FEBS JOURNAL (2013)

Article Oncology

Complications of Radioactive Iodine Treatment of Thyroid Carcinoma

Stephanie L. Lee

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2010)

Review Oncology

E2F-1 as an anticancer drug target

Joseph R. Bertino et al.

ONCOLOGY REVIEWS (2009)

Article Biochemistry & Molecular Biology

BMI1 is a target gene of E2F-1 and is strongly expressed in primary neuroblastomas

K Nowak et al.

NUCLEIC ACIDS RESEARCH (2006)

Article Multidisciplinary Sciences

c-Myc-regulated microRNAs modulate E2F1 expression

KA O'Donnell et al.

NATURE (2005)

Article Genetics & Heredity

Up-regulation of transcriptional factor E2F1 in papillary and anaplastic thyroid cancers

M Onda et al.

JOURNAL OF HUMAN GENETICS (2004)